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Background: Dengue virus infection (DVI) is very common infection. There is scarcity of data on factor associated
with increased hospital stay and mortality in dengue virus infection (DVI). This study was done to know about
factors associated with increased hospital stay and mortality in patients admitted with DVI.
Results: Out of 532 patients, two third (72.6%) had stay ≤3 days while one third (27.4%) had stay greater than
3 days. The mean length of hospital stay was 3.46 ± 3.45 days. Factors associated with increased hospital stay
(>3 days) included AKI (acute kidney injury) (Odd ratio 2.98; 95% CI 1.66-5.34), prolonged prothrombin time
(Odd ratio 2.03; 95% CI 1.07-3.84), prolonged activated partial thromboplastin time (aPTT) (Odd ratio 1.80; CI 95%
1.15-2.83) and increased age of > 41.10 years (Odd ratio 1.03; CI 95% 1.01-1.04).Mortality was 1.5%. High mortality
was found in those with AKI (P <0.01), dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)
(P <0.001), respiratory failure (P0.01), prolong PT (P 0.001), prolong aPTT (P0.01) and increased hospital stay (P0.04).
Conclusion: Increasing age, coagulopathy and acute kidney injury in patients with DVI is associated with increased
hospital stay. Morality was more in patients with AKI, DHF and DSS, respiratory failure, coagulopathy and these
patients had more prolonged hospitalization.
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Dengue virus infection (DVI) is mosquito born disease
and is a growing health problem in the world. Due to
the advent increase in trade activities and tourism, the
virus has been inadvertently transferred from endemic
regions to other parts of the world [1,2]. The number of
countries reporting DVI has increased from nine in 1950
to over 100 countries over the past few decades. As a re-
sult, over 50 million people are infected by DVI and
around 2.5 billion people are at risk [3].
Dengue virus infection causes significant morbidity
and mortality. There are four serotypes (DEN 1–4), clas-
sified according to biological and immunological criteria.
The virus is transmitted by mosquitoes. The clinical* Correspondence: doctrokhalil1975@hotmail.com
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unless otherwise stated.manifestations vary in presentation from mild constitu-
tional symptoms to severe infections causing dengue
hemorrhagic fever (DHF) and dengue shock syndrome
(DSS). Asymptomatic infections are mild and can be
treated as an outpatient. DSS and DHF, on the other
hand require admission and treatment in special units
equipped with intensive facilities. Dengue was first docu-
mented in 1982 in Pakistan [4]. Pakistan had multiple
epidemics since the first literature documented epidemic
in 1994 [5]. The virus is now endemic in all provinces of
the country [6,7]. Recent epidemics in Pakistan had caused
significant burden and stress on health care facilities.
Dengue is associated with significant morbidity and
mortality. Both DSS and DHF have bad expected out-
come if not vigilantly picked up and treated. The identi-
fication of factors associated with prolong hospital stay
and mortality can potentially identify sick patients who
can be treated with supportive measures in a specialtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ity and mortality. Identification of these risk factors can
be incorporated into patient assessment and manage-
ment protocol to provide better care. To date, there is
no literature evidence on length of hospital stay and fac-
tors associated with increased hospital stay and mortal-
ity. With this in mind, this study was designed to
investigate and identify potential factors that may deter-




This retrospective study was conducted at Aga Khan
University Hospital Karachi Pakistan.
Study setting
Aga Khan University Hospital is a tertiary care health
facility located in the biggest city in Pakistan. It has
15 inpatient units with a total capacity of 563 beds
and is also the tertiary referral center for advance
diagnostic procedures and management. Study was con-
ducted at the department of medicine taking care of adult
patients.
Study population and sampling
Study subjects included in-patients admitted with a pri-
mary diagnosis of DVI and were identified from com-
puterized records from January 2008 to December 2010.
Study subjects included patients with age greater than 14
years admitted with the primary diagnosis of DVI and
confirmed dengue IgM antibodies confirmed by ELISA,
irrespective of severity of DVI. Patients with no laboratory
evidence of DVI and those with malaria were excluded.
Data on demographics, clinical features, laboratory data,
length of stay and mortality were noted on a proforma.
Study tools and data management
Records of the cases were retrieved through codes using
international classification of disease (ICD) 9 CM 061
for DVI and international classification of disease (ICD)
9 CM 065.4 for DHF and DSS. Most studies have repor-
ted median hospital stay of 3-4 days in patients with
DVI [8,9]. Therefore, we divided the length of hospital
stay divided into less than or equal to 3 days and greater
than 3 days and these two cohorts were compared for
variables that might determine predictors for increased
hospital stay. Similar comparisons were done between
patients who survived and those who died. WHO 1997
classification was used to classify dengue virus infection
into dengue fever (DF), dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS) [10]. We used Acute
Kidney Injury Network (AKIN) definition for classifi-
cation of AKI [11]. AKIN stage 1 AKI was defined asan increase in serum creatinine greater than 26.5 μmole/
litre (≥0.3 mg/dl) or 1.5 to 2 fold increase from baseline.
AKIN stage 2 AKI was defined as an increase in serum
creatinine of greater than 2-3 folds from baseline. AKIN
stage 3 AKI was defined as an increase in serum creatinine
of greater than 3 fold from baseline or an absolute serum
creatinine of greater than 354 μmole/litre (≥4 mg/dl). Mild
hepatitis was defined as ALT 45-300 IU/L and severe
hepatitis was defined as ALT >300 IU/L.
Ethical consideration
Ethical approval was taken from both departmental and
hospital Ethical Review Committee.
Statistical analysis
Descriptive statistics were used to summarize baseline
values and demographic data. Quantitative and qualitative
data were expressed as mean, median, interquartile range
(IQR) and standard deviation (SD) and number of obser-
vations with percentage (%) respectively. To evaluate the
association between outcomes (length of hospital stay) and
each of factors, x2 -test or Fisher’s exact tests of independ-
ence were used to compare proportions where appropriate,
and the Student’s t-test was used to analyze continuous
data. Odds Ratios (OR) and their 95% Confidence Intervals
(CI) were estimated using binary logistic regression, with
length of hospital stay (≤3 versus >3 days) as outcomes.
Multivariable models were constructed, including variables
that showed an effect in the prediction of length of hospital
stay >3 days in the univariate analysis. All p-values were
based on two-sided tests and significance was set at a
p-value less than 0.05. The analyses were performed using
SPSS (Statistical Package of Social Sciences) version 19.
Results
Of the 532 patients, two thirds (70.9%) were male. The
mean age was 35.2 ± 14.7 years (range 15-85 years). Den-
gue fever was found in majority of the patients (84.4%).
DHF and DSS were present only in 76 (14.3%) and 7
(1.3%) patients respectively. All cases of dengue fever,
DHF and DSS were dengue IgM antibodies positive by
ELIZA. Seventy one (13.3%) patients developed AKI.
Mild and severe hepatitis were present in 329 (61.8%)
and 47 (8.8%) patients respectively. Prolongation of pro-
thombin time was found in 64 (12%) while 225 (42.3%)
patients had prolonged aPTT. Fourteen (2.6%) patients
had respiratory failure and 11 (2.1%) patients had neuro-
logical involvement (Table 1).
The mean hospital stay was 3.46 days ± 3.45; Median 3
[IQR; 2-4]. Three hundred and eighty six patients (72.6%)
had a length of stay ≤3 days. One hundred and forty six
patients (27.4%) had a length of stay > 3 days. The total
numbers of patients with DVI progressively increased
from 2008 to 2010 (Table 1). Potential determining factors
Table 1 Characteristics of the dengue virus infection cases (n = 532)
Variables Mean ± standard deviation Median/Range/Percentages




Length of hospital stay 3.46 ± 3.45 3(1-33 days); 3[2-4]
Peak creatinine (μmole/litre) 98.124 ± 83.98 79.56(17.68-875.16)
Peak creatinine in AKI (μmole/litre) 229.84 ± 174.15 149.6(114.92-875.16)
Admission creatinine (μmole/litre) 90.16 ± 61.88 79.56(17.68-857.48)
Admission hematocrit (Proportion of 1.0) 0.4102 ± 0.063 0.415(0.199-0.58)
Peak hematocrit (Proportion of 1.0) 0.422 ± 0.0563 0.424(0.264-0.58)
Platelets 38.65 ± 42.14 23(2-427)
Alanine aminotransferase (μkat/L) 2.73 ± 5.86 1.27(0.050-60.55)
Prothrombin time (Seconds) 12.82 ± 8.70 11.10(3-120)
aPTT (Seconds) 36.02 ± 15.12 33.35(11.2-120)
Vasopressin 5 0.9%
Central nervous system involvement 11 2.1%
Respiratory failure 14 2.6%
World Health Organization Classification
Dengue fever 449 84.4%
Dengue hemorrhagic fever 76 14.3%
Dengue shock syndrome 7 1.3%
Length of stay in hospital
≤3 days 386 72.6%
>3 days 146 27.4%
Alanine aminotransferase
Normal 156 29.3%
Mild hepatitis 0.75 - 5.01 μkat/L 329 61.8%




Activated partial thromboplastin time (Seconds)
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logistic regression analysis. AKI was found an independent
predictor for increased length of stay greater than 3 days
(Odd ratio 2.98; 95% CI 1.66-5.34). Other independent
predictors for increased length of stay greater than 3 days
included prolong prothrombin time (PT) (Odd ratio 2.03;
95% CI 1.07-3.84), prolong activated partial thromboplas-
tin time (aPTT) (Odd ratio 1.80; 95% CI 1.15-2.83) and
increasing age (Odd ratio 1.03; 95% CI 1.01-1.04) (Table 2).
Although univariate analysis showed respiratory failure
(P <0.001), neurological involvement (P = 0.04) and hepatitis
(P value 0.02) were significant associated with increased
hospital stay, however these finding were not reciprocated
by multivariate analysis (Table 3).
Mean hospital stay was 10.63 ± 8.434 days in those who
died. High mortality (n = 8; 1.5%) was found in those with
AKI (P <0.01), dengue hemorrhagic fever (DHF) and den-
gue shock syndrome (DSS) (P <0.001), respiratory failure
(P0.01), prolong PT (P 0.001), prolong aPTT (P0.01) and
increased hospital stay (P0.04) (Table 2).
Discussion
Dengue and DHF have emerged as some of the most




Age, in years 35.0 ± 14
Acute kidney injury 63(12)
World Health Organization Classification
Dengue fever 447(85.3
Dengue hemorrhagic fever 73(13.9)
Dengue shock syndrome 4(0.8)













Length of stay 3.3 ± 3.2
Median [IQR] 3[2-4]epidemics of DVI, dengue is now endemic in all prov-
inces of Pakistan and it is in fact a growing public health
problem in Pakistan. Our patient demographics are not
dissimilar to other DVI patients reported in the litera-
ture. Like other South Asian studies, there is a male pre-
ponderance for DVI. Studies from India and Singapore
reported male to female ratio of 1.9: 1and 1:0.57 respect-
ively [7,12]. This may be because men are more likely to
have better access to healthcare in our society compared
to women who are less likely to be taken for care at a
hospital when ill. Secondly males may be more exposed
to mosquito bites from outdoor sources due to their
increased outside home activities.
Regarding length of hospital stay, “one third” of patients
with DVI had a prolonged hospital stay. The mean hos-
pital stay reported in our study was 3.46 days. Various
studies done at national and international level reported a
mean stay of 3.4-6.2 days which are comparable to our
results [7-9,12]. We specifically concentrated on this latter
group of patients who had a prolonged stay at hospital of
greater than 3 days. Presence of AKI, increasing age and
coagulopathy were associated with increased hospital stay.
AKI was present in 13.3% patients admitted with DVI.
AKI in DF results from hypoperfusion and hypoxia fromte analysis
e P value
ge n = 524 Death n = 8















10.6 ± 8.4 0.04
10[2-17.75]
Table 3 Predictors of length of hospital stay in individuals aged≥ 14 years hospitalized for dengue virus infection (n = 532)
Variable Univariate analysis Multivariate analysis
Length of stay in hospital P value Odd ratio [95% CI] P value
≤ 3 days n = 386 >3 days n = 146
Age, in years 33.10 ± 13 41.10 ± 17.20 <0.001 1.03[1.01-1.04] <0.001
Acute kidney injury 29(7.5) 42(28.8) <0.001 2.98[1.66-5.34] <0.001
World Health Organization Classification
Dengue fever 329(85.2) 120(82.2) 0.002 1.0
Dengue hemorrhagic fever 56(14.5) 20(13.7) 0.91[0.49-1.69] 0.76
Dengue shock syndrome 1(0.3) 6(4.1) 2.37[0.23-24.2] 0.46
Central nervous system 5(1.3) 6(4.1) 0.04 0.79[0.17-3.6] 0.76
Diabetes mellitus 28(7.3) 19(13) 0.03 0.84[0.38-1.87] 0.68
Hypertension 26(6.7) 22(15.1) 0.003 1.13[0.50-2.51] 0.76
Respiratory failure 4(1) 10(6.8) <0.001 3.2[0.76-13.3] 0.11
Alanine aminotransferase
Normal 110(28.5) 46(31.5) 0.02
Mild hepatitis 249(64.5) 80(54.8)
Severe hepatitis 27(7) 20(13.7)
Prothrombin time (Seconds)
≤ 15 353(91.5) 115(78.8) <0.001
> 15 33(8.5) 31(21.2) 2.03[1.07-3.84] 0.02
Activated partial thromboplastin time (Seconds)
≤ 35 243(63) 64(43.8) <0.001
>35 143(37) 82(56.2) 1.80[1.15-2.83] 0.01
Platelets (Micro/litre)
<50000 295(76.4) 111(76) 0.12 1.0
50000-100000 70(18.1) 23(15.8) 0.23[0.04-1.13] 0.07
100000-150000 17(4.4) 6(4.1) 0.31[0.03-1.1] 0.11
>150000 4(1) 6(4.1) 0.36[0.06-1.88] 0.22
Death 2(0.5) 6(4.1) 0.002 0.86[0.13-5.4] 0.87
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0.9% to 10.8% [13-15] in patients with DVI and associated
with increased mortality [15]. We found the presence of
AKI associated with prolonged stay in hospital in patients
with dengue virus infection.
Significant number of our study patients showed coag-
ulopathy manifested by abnormality of both extrinsic
and intrinsic pathway in patients with DVI. Coagulopathy
is now a well-established fact [16,17]. Coagulopathy is
multifactorial and may be due to low platelets, deranged
PT, aPTTand hepatitis. In addition to AKI we found coag-
ulopathy and increasing age as important predictors asso-
ciated with increased hospital stay. Although we found
hepatitis and thrombocytopenia in a significant number of
patients but neither of these had an impact on hospital
stay. The mortality rate from our study was 1.5%. Various
studies from Pakistan have reported mortality of 2.6%-
2.7% in general population infected with DVI [18,19].International data reports a variable mortality ranging
from 0-3.7% [20-23]. However it was interesting to note
that all those patients who died had AKI. Similarly
mortality was more in those who had a prolong hospital
stay, respiratory failure, DHF and DSS, and coagulopathy.
However the number of patients died in our cohort was
very small (n = 8) to compare with those who survived.
Therefore, larger cohorts are needed to study various fac-
tors associated with mortality.
Increasing age in combination with AKI and coagulo-
pathy might denote seriously sick patients who can poten-
tially have more morbidity in the form of increased
hospital stay. These patients also had more propensity to
die. AKI might be due to vascular leakage and coagulopa-
thy in patients with DVI. Therefore the combination of
AKI, coagulopathy with increasing age in patients with
DVI might put them at risk to develop ischemia of various
organs resulting in increased hospital stay. Therefore, these
Khalil et al. BMC Research Notes 2014, 7:473 Page 6 of 7
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preferably in a special care set up to avoid morbidity and
mortality. To the best of our knowledge, these factors have
never been formally implicated in the literature in increas-
ing hospital stay. The presence of these factors in severely
ill patients may have necessitated the use of advanced
therapies like renal replacement therapy or ventilator
support which would have delayed hospital discharge.
These patients were also more likely to have co-existing
haemodynamic disturbances and bacterial septicaemia
which would have required treatment with inotropes and
antibiotics. Furthermore, older patients would have other
co-morbidities and have rehabilitational issues which may
complicate admissions and extend hospital stay.
We acknowledge that there are several limitations in
this study. The retrospective nature of data collection
may have biased the findings towards patients who are
more unwell and hence more likely to be captured and
recorded by the system. We would have liked to grade
DHF if the study is done prospectively as it would have
enabled us to diagnose early DHF which may have been
undetected and unrecorded by our coders. We also ac-
knowledge that criteria for admission and discharges
may have been variable among various clinicians taking
care of these patients and could interfere with the results
of our findings. To asses factors associated with mortal-
ity more larger cohort of patients is needed. Moreover,
the study population included adults patients and hence
its results cannot be generalized to pediatric patients.
The study is also limited to one center and may not be
representative of the population as a whole.
Conclusion
Acute kidney injury, coagulopathy and increase age are
associated with prolonged hospital stay. Mortality is com-
moner in those with AKI and prolonged hospital stay.
With these in mind we advise extra vigilance and caution-
ary strategies when encountering DVI patients with these
risk factors. More studies are needed to investigate pre-
ventive strategies on minimizing the occurrences of these
potential deleterious factors.
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